Skip to content
ContentLora

    Tip: press / anywhere to search.

    Explainer

    COVID-19 explained: symptoms, tests, vaccines and 2026-27 advice

    COVID-19 is a disease caused by the SARS-CoV-2 coronavirus. Most people recover without treatment, but older adults, people with underlying conditions and unvaccinated people face a higher risk of severe illness.[1][2] For 2026-27 the FDA approved updated vaccines targeting the XFG variant for people 65 and older and younger people with high-risk conditions, while the CDC says its broader July 2025 recommendations remain in effect because of legal uncertainties.[3][4][5]

    Editor reviewedStrict sourcingUpdated Explainer48 claims · 100% primaryInfectious disease, Health and medicine
    Reading level: 1 passage differs; the rest is the same for everyone.

    This page is general information, not medical advice. If you are unwell, have questions about testing, treatment or vaccination, or are unsure whether a vaccine is right for you, talk to a doctor, pharmacist or your local health service. In an emergency, call your local emergency number. This page summarises guidance from health agencies (WHO, CDC, FDA and the NHS), which draws on published studies and surveillance. Where an agency says the evidence is limited, we say so.

    COVID-19 is a disease caused by the SARS-CoV-2 coronavirus.[1] WHO says nearly 780 million cases and more than 7.1 million deaths had been reported worldwide since December 2019, and that the true numbers are thought to be higher.[6] In the United States, CDC says nearly 1.2 million people had died of COVID-19 by 1 June 2024.[7] WHO ended the global public health emergency in May 2023 and has since moved to managing the disease for the long term.[8]

    The virus and how it spreads

    SARS-CoV-2 spreads through the air in infectious respiratory particles released when an infected person breathes, talks, coughs or sneezes.[9] Anyone who is infected can pass it on, even without symptoms, and WHO says people can be infectious in the days before symptoms appear.[9][10] WHO says the virus circulates all year without an established seasonal pattern.[11]

    Older adults, people with underlying health conditions and unvaccinated people are at higher risk of severe illness. CDC says the risk rises with age, especially from 75.[2] WHO says severe COVID-19 can lead to respiratory failure, sepsis, blood clots, multiorgan failure and death.[12]

    Symptoms and when to get help

    WHO lists fever, chills and sore throat as the most common symptoms for the variants now circulating, with fatigue, headache, a new persistent cough, shortness of breath and changes to taste or smell among the less common ones.[13] CDC’s list of possible symptoms also includes congestion, muscle aches, nausea or vomiting and diarrhea, and it notes that symptoms may change with new variants.[14] Symptoms usually start 3 to 6 days after exposure and last up to 10 days.[10] The NHS says they look very similar to colds and flu, and most people feel better within a few weeks.[15]

    CDC advises people with symptoms not better explained by something else to stay home and away from others.[16] The NHS asks adults who test positive to try to stay home and avoid others for 5 days after the test, and children and young people for 3 days.[17]

    CDC’s emergency warning signs include trouble breathing, persistent chest pain or pressure, new confusion, being unable to wake or stay awake, and pale, gray or blue lips, nail beds or skin. It says to call 911 if someone shows them.[18] WHO gives a similar list for seeking immediate care.[19]

    Testing and treatment

    Flu and COVID-19 cannot be told apart by symptoms alone, so a test is needed. Some PCR tests check for both at once.[20][21] CDC says lab-based nucleic acid amplification tests (NAATs) such as PCR are more likely to detect the virus than antigen tests. Antigen tests, including home self-tests, usually give results in 15 to 30 minutes.[22] A single negative antigen test cannot rule out infection, so CDC passes on the FDA advice to repeat negative tests 48 hours apart.[23] Some tests, especially NAATs, can stay positive for up to 90 days after an infection.[24]

    CDC says FDA-authorized or approved antiviral medicines can treat mild to moderate COVID-19 in people more likely to get very sick, and that treatment must start within 5 to 7 days of the first symptoms.[25] A positive test is not needed to start, so people at high risk are told to contact a healthcare provider as soon as they feel ill.[26] CDC names Paxlovid and Lagevrio as oral antivirals. It says Paxlovid is more likely than other COVID-19 antivirals to interact with other medicines, though most people can still take it.[27]

    Long COVID

    WHO estimates that about 6 in 100 people who have COVID-19 develop post COVID-19 condition, often called long COVID. Its symptoms usually start within 3 months of the illness and last at least 2 months. WHO says limited data suggest the chance of developing it is lower now than earlier in the pandemic.[28] Common symptoms include fatigue, breathlessness, muscle or joint pain and poor sleep.[29] Anyone infected can develop it, but WHO says risk is higher for women, older adults, smokers, people with overweight or chronic conditions, and after repeated or severe infections.[30] The evidence is limited: WHO says most estimates come from people infected in the first two years of the pandemic and vary very widely, and that newer data come mostly from high-income countries.[31]

    Vaccines and the 2026-27 recommendations

    WHO says COVID-19 vaccines have saved millions of lives by protecting against severe disease, hospital stays and death.[32] They do much less to stop the virus spreading.[33] The vaccine is updated as the virus changes, and who is advised to get it differs between countries.[34][35]

    The first authorized mRNA COVID-19 vaccines encode the SARS-CoV-2 spike protein in lipid nanoparticles (see how mRNA vaccines work).[36] WHO says COVID-19 vaccines protect against severe disease and death but have limited impact on transmission.[33] Its advice is risk-based, with revaccination 6 to 12 months after the last dose for high-priority groups such as older adults, people with severe obesity or several serious conditions, immunocompromised people, pregnant women and health workers.[37]

    United States. After its advisers met on 28 May 2026, the FDA told manufacturers that 2026-27 vaccines should target the JN.1-lineage XFG variant.[34] On 27 August 2026 it approved updated Comirnaty, Spikevax and mNEXSPIKE mRNA vaccines and Novavax’s protein-based Nuvaxovid.[3] The approvals kept the narrower eligibility the FDA set in 2025: everyone 65 and older, plus younger people with at least one high-risk condition.[4][38]

    CDC’s recommendations follow a separate track. In September 2025 the reconstituted Advisory Committee on Immunization Practices (ACIP) voted for COVID-19 vaccination based on individual decision-making for people 6 months and older.[39] In March 2026 a federal court stayed the new members’ appointments and all of the committee’s votes since June 2025.[40] As of 7 November 2026, CDC listed its 2026 ACIP meetings as cancelled because of the litigation.[41] CDC says that, because of these legal uncertainties, the COVID-19 recommendations in its July 2025 schedule stay in effect for 2026-27.[5] Those recommend a vaccine for all adults 18 and older and for children 6 months to 17 years with moderate to severe immunocompromise, with shared decision-making for other children.[42] CDC marks uses outside the FDA label as off-label and says patients should discuss benefits and risks with their providers.[43] For children aged 6 months to 4 years, Moderna’s Spikevax is the only FDA-approved option.[44] The wider policy dispute is covered in the US mRNA vaccine policy debate.

    England. The NHS offers the 2026-27 winter vaccine to people 75 and older, people aged 6 months to 74 years with a weakened immune system and care-home residents, until 31 January 2027.[35] It says the most common side effects are mild and pass within a week, while rare cases of heart inflammation (myocarditis) have been reported.[45]

    How COVID-19 is tracked

    CDC tracks respiratory virus activity with an acute respiratory illness (ARI) metric and follows the share of emergency department visits linked to COVID-19, flu and RSV. Wastewater testing gives a further signal.[46] The ARI metric sorts activity into five levels, from very low to very high.[47] In Europe, ECDC reported in week 44 of 2026 that respiratory illness was at baseline or low levels, with SARS-CoV-2 the main contributor.[48]

    Vaccine eligibility and advice differ between countries and can change during the season. Check your national health agency or ask a pharmacist. For flu and RSV, see the related explainers; for the season’s flu data, see the 2026-27 flu season tracker.

    Questions readers ask

    What are the most common COVID-19 symptoms now?

    WHO lists fever, chills and sore throat as the most common symptoms for currently circulating variants. CDC's list of possible symptoms also includes cough, shortness of breath, congestion, new loss of taste or smell, fatigue, aches, headache, nausea or vomiting and diarrhea.[13][14]

    How soon do symptoms start, and when am I contagious?

    WHO says symptoms usually begin 3 to 6 days after exposure and last up to 10 days. People can spread the virus before symptoms start or without any symptoms.[10][9]

    Can a home test rule out COVID-19?

    Not a single negative one. CDC says one negative antigen test cannot rule out infection, and passes on the FDA advice of 2 negative antigen tests 48 hours apart for people with symptoms, or 3 for people without.[23]

    Is there treatment for COVID-19?

    Yes, for people more likely to get very sick. CDC says FDA-authorized or approved antivirals can treat mild to moderate COVID-19 in that group, and treatment must start within 5 to 7 days of the first symptoms. A positive test is not required to start.[25][26]

    Who is the 2026-27 COVID-19 vaccine for in the US?

    The FDA approved 2026-27 vaccines for everyone 65 and older and younger people with at least one high-risk condition. CDC's clinical considerations recommend a vaccine for all adults 18 and older, mark uses outside the FDA label as off-label, and say patients should discuss benefits and risks with their providers.[4][42][43]

    What is long COVID?

    WHO calls it post COVID-19 condition. It estimates about 6 in 100 people who have COVID-19 develop it, with symptoms that usually start within 3 months and last at least 2 months, such as fatigue, breathlessness, muscle or joint pain and poor sleep.[28][29]

    When should someone get emergency help?

    CDC's warning signs include trouble breathing, persistent chest pain or pressure, new confusion, being unable to wake or stay awake, and pale, gray or blue lips, nail beds or skin. It says to call 911 if someone shows them.[18]

    Sources

    · 48 claims from 14 publishers

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      COVID-19 is a disease caused by the SARS-CoV-2 coronavirus. confirmedas of 2026-11-07

    2. [2]

      Older adults, people with underlying health conditions and unvaccinated people are at higher risk of severe COVID-19; CDC says risk rises with age, especially from 75. confirmedas of 2026-11-07

    3. [3]

      On 27 August 2026 the FDA approved 2026-2027 formula versions of the mRNA vaccines Comirnaty, Spikevax and mNEXSPIKE, which target the XFG variant; Novavax's protein-based Nuvaxovid was also approved for the season. confirmedas of 2026-08-27

    4. [4]

      The 2026-2027 approvals kept the narrower US eligibility set in 2025, covering everyone 65 and older plus younger people with at least one high-risk condition, from age 5 for Comirnaty, 6 months for Spikevax and 12 for mNEXSPIKE. confirmedas of 2026-08-28

    5. [5]

      CDC says that, because of legal uncertainties, the COVID-19 vaccination recommendations in its July 2025 immunisation schedule remain in effect for the 2026-2027 respiratory season. confirmedas of 2026-09-23

    6. [6]

      WHO says nearly 780 million COVID-19 cases and more than 7.1 million deaths have been reported worldwide since December 2019, and that the actual numbers are thought to be higher. confirmedas of 2026-11-07

    7. [7]

      CDC says that as of 1 June 2024 nearly 1.2 million people had died of COVID-19 in the United States. confirmedas of 2024-06-01

      • About COVID-19 · Centers for Disease Control and Prevention · Primary source · Overview (retrieved 2026-11-07)
    8. [8]

      WHO's Director-General ended the COVID-19 Public Health Emergency of International Concern in May 2023, and WHO has since shifted to long-term management of the disease. confirmedas of 2026-11-07

    9. [9]

      SARS-CoV-2 spreads through the air in infectious respiratory particles when an infected person breathes, talks, coughs or sneezes, and CDC says anyone infected can spread it even without symptoms. confirmedas of 2026-11-07

    10. [10]

      WHO says COVID-19 symptoms usually begin 3 to 6 days after exposure and last up to 10 days, and that infected people can spread the virus without symptoms or before symptoms start. confirmedas of 2026-11-07

      • Coronavirus disease (COVID-19) fact sheet · World Health Organization · Primary source · Transmission (the sentence begins 'Symptoms usually begin 3–6 days*'; the dash is an HTML entity; 'up to10' is WHO's typo) (retrieved 2026-11-07)
    11. [11]

      WHO says SARS-CoV-2 circulates throughout the year without an established seasonal pattern. confirmedas of 2026-11-07

    12. [12]

      WHO says severe COVID-19 can lead to respiratory failure, sepsis, blood clots, multiorgan failure and death. confirmedas of 2026-11-07

    13. [13]

      WHO lists fever, chills and sore throat as the most common COVID-19 symptoms for currently circulating variants; less common ones include fatigue, headache, a new persistent cough, shortness of breath and loss or change of taste or smell. confirmedas of 2026-11-07

    14. [14]

      CDC's list of possible COVID-19 symptoms includes fever or chills, cough, shortness of breath, sore throat, congestion, new loss of taste or smell, fatigue, aches, headache, nausea or vomiting and diarrhea, and it says symptoms may change with new variants. confirmedas of 2026-11-07

      • Symptoms of COVID-19 · Centers for Disease Control and Prevention · Primary source · Symptoms list (fever or chills, cough, shortness of breath, sore throat, congestion or runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting, diarrhea) (retrieved 2026-11-07)
    15. [15]

      The NHS says COVID-19 symptoms are very similar to those of other illnesses such as colds and flu, and that most people feel better within a few weeks. confirmedas of 2026-11-07

    16. [16]

      CDC advises people with COVID-19 symptoms not better explained by another cause to stay home and away from others. confirmedas of 2026-11-07

      • Symptoms of COVID-19 · Centers for Disease Control and Prevention · Primary source · Feeling sick? (retrieved 2026-11-07)
    17. [17]

      The NHS advises adults who test positive to try to stay at home and avoid other people for 5 days after the test, and children and young people for 3 days. confirmedas of 2026-11-07

    18. [18]

      CDC's emergency warning signs for COVID-19 include trouble breathing, persistent chest pain or pressure, new confusion, inability to wake or stay awake, and pale, gray or blue lips, nail beds or skin; it says to call 911 if someone shows them. confirmedas of 2026-11-07

      • Symptoms of COVID-19 · Centers for Disease Control and Prevention · Primary source · When to seek emergency help (list: trouble breathing; persistent pain or pressure in the chest; new confusion; inability to wake or stay awake; pale, gray or blue lips, nail beds and skin) (retrieved 2026-11-07)
    19. [19]

      WHO says people with difficulty breathing, confusion, drowsiness or loss of consciousness, or persistent chest pain or pressure should seek immediate medical attention. confirmedas of 2026-11-07

    20. [20]

      CDC says flu and COVID-19 cannot be told apart by symptoms alone, and that some PCR tests check for both at once. confirmedas of 2026-11-07

      • Symptoms of COVID-19 · Centers for Disease Control and Prevention · Primary source · Difference between flu and COVID-19 (retrieved 2026-11-07)
      • Symptoms of COVID-19 · Centers for Disease Control and Prevention · Primary source · Difference between flu and COVID-19 (retrieved 2026-11-07)
    21. [21]

      Flu and COVID-19 are both contagious respiratory illnesses caused by different viruses, and the CDC says testing is needed to confirm which one a person has. confirmedas of 2026-11-07

    22. [22]

      CDC says lab-based NAATs such as PCR tests are more likely to detect the virus than antigen tests, which are rapid tests that usually give results in 15 to 30 minutes. confirmedas of 2026-11-07

    23. [23]

      CDC says a single negative antigen test cannot rule out infection, and passes on the FDA recommendation of 2 negative antigen tests 48 hours apart for people with symptoms, or 3 for people without. confirmedas of 2026-11-07

    24. [24]

      CDC says some tests, especially NAATs, can stay positive for up to 90 days after an infection. confirmedas of 2026-11-07

    25. [25]

      CDC says FDA-authorized or approved antivirals can treat mild to moderate COVID-19 in people more likely to get very sick, and that treatment must start within 5 to 7 days of the first symptoms. confirmedas of 2026-11-07

    26. [26]

      CDC says a positive test is not needed to start COVID-19 treatment, and that people at high risk should talk to a healthcare provider as soon as they get sick. confirmedas of 2026-11-07

    27. [27]

      CDC names Paxlovid and Lagevrio as oral COVID-19 antivirals and says Paxlovid is more likely than other COVID-19 antivirals to interact with other medicines, though most people can still take it. confirmedas of 2026-11-07

    28. [28]

      WHO estimates that about 6 in 100 people who have COVID-19 develop post COVID-19 condition (long COVID), with symptoms that usually start within 3 months and last at least 2 months; limited data suggest the chance is lower now than earlier in the pandemic. confirmedas of 2026-11-07

    29. [29]

      WHO lists fatigue, breathlessness, muscle or joint pain and impaired sleep as common symptoms of long COVID. confirmedas of 2026-11-07

    30. [30]

      WHO says anyone infected with SARS-CoV-2 can develop long COVID, and that risk is higher for women, older adults, smokers, people with overweight or chronic conditions, and after repeated or severe infections. confirmedas of 2026-11-07

    31. [31]

      WHO says long COVID estimates largely come from people infected in the first two years of the pandemic and vary very widely, and that newer data suggesting a lower risk are limited and mostly from high-income countries. confirmedas of 2026-11-07

    32. [32]

      WHO says COVID-19 vaccines have saved millions of lives by protecting against severe disease, hospitalisation and death, and that over 13.64 billion doses had been given by the end of 2024. confirmedas of 2026-11-07

    33. [33]

      WHO says COVID-19 vaccines protect against severe disease and death but have limited impact on reducing transmission. confirmedas of 2026-11-07

    34. [34]

      After its vaccine advisory committee met on 28 May 2026, the FDA advised manufacturers that 2026-2027 COVID-19 vaccines for the US should be monovalent vaccines targeting the JN.1-lineage XFG variant. confirmedas of 2026-05-29

    35. [35]

      In England, the NHS offers the 2026-27 winter COVID-19 vaccine to people aged 75 and over, people aged 6 months to 74 years with a weakened immune system and care-home residents, with a last vaccination date of 31 January 2027. confirmedas of 2026-11-07

      • COVID-19 vaccine · NHS · Primary source · Who can get the COVID-19 vaccine (retrieved 2026-11-07)
      • COVID-19 vaccine · NHS · Primary source · How to get the vaccine (retrieved 2026-11-07)
    36. [36]

      The first authorized mRNA COVID-19 vaccines, Pfizer-BioNTech's BNT162b2 and Moderna's mRNA-1273, both encode the SARS-CoV-2 spike protein and are formulated in lipid nanoparticles. confirmedas of 2023-03-01

    37. [37]

      WHO recommends COVID-19 vaccination using a risk-based approach, with revaccination 6 to 12 months after the last dose for high-priority groups such as older adults, people with severe obesity or multiple serious conditions, immunocompromised people, pregnant women and health workers. confirmedas of 2026-11-07

    38. [38]

      In August 2025 the FDA limited the approved use of Pfizer-BioNTech's Comirnaty to people 65 and older and younger people with at least one condition that puts them at high risk of severe COVID-19. confirmedas of 2025-08-25

    39. [39]

      On 19 September 2025 ACIP voted to recommend COVID-19 vaccination based on individual-based (shared clinical) decision-making for people 6 months and older, and rejected a proposal to require prescriptions. confirmedas of 2025-09-19

    40. [40]

      On 16 March 2026 a federal district court in Massachusetts, in American Academy of Pediatrics v. Kennedy, stayed the 13 ACIP appointments and all votes of the reconstituted committee since June 2025. confirmedas of 2026-03-17

    41. [41]

      As of 7 November 2026, CDC listed ACIP's last meeting as 4-5 December 2025 and its March, June and October 2026 meetings as cancelled due to ongoing litigation, with meetings scheduled for 2027. confirmedas of 2026-11-07

      • ACIP Meetings · Centers for Disease Control and Prevention · Primary source · 2026-10-09 · Read through WebFetch (cdc.gov blocks curl) on 2026-11-07 about 15:15 UTC; page updated 9 October 2026 (retrieved 2026-11-07)
      • ACIP Meetings · Centers for Disease Control and Prevention · Primary source · 2026-10-09 · Re-checked by reviewer through WebFetch on 2026-11-07; 2025 list ends "December 4-5, 2025"; 2027 list starts "February 24-26" (retrieved 2026-11-07)
      • ACIP Meetings · Centers for Disease Control and Prevention · Primary source · 2026-10-09 · Re-checked by reviewer through WebFetch on 2026-11-07 (retrieved 2026-11-07)
    42. [42]

      CDC's 2026-2027 clinical considerations recommend a COVID-19 vaccine for all adults 18 and older and for children 6 months to 17 years with moderate to severe immunocompromise, and shared clinical decision-making for other children. confirmedas of 2026-09-23

    43. [43]

      CDC's 2026-2027 guidance marks where its recommendations go beyond the FDA-approved indication as off-label, and says patients should discuss the benefits and risks of vaccination with their healthcare providers. confirmedas of 2026-09-23

    44. [44]

      CDC says the Pfizer-BioNTech COVID-19 vaccine is no longer authorized for children aged 6 months to 4 years, leaving Moderna's Spikevax as the only FDA-approved COVID-19 vaccine for that age group. confirmedas of 2026-09-23

    45. [45]

      The NHS says the most common COVID-19 vaccine side effects are mild and pass within a week, that severe allergic reactions are very rare, and that rare cases of heart inflammation (myocarditis) have been reported. confirmedas of 2026-11-07

      • COVID-19 vaccine · NHS · Primary source · Side effects (retrieved 2026-11-07)
      • COVID-19 vaccine · NHS · Primary source · Side effects (retrieved 2026-11-07)
    46. [46]

      CDC tracks respiratory virus activity with an acute respiratory illness (ARI) metric, follows the share of emergency department visits linked to COVID-19, flu and RSV, and also uses wastewater testing. confirmedas of 2026-11-07

    47. [47]

      CDC's ARI metric sorts the share of emergency department visits into five activity levels, from very low to very high. confirmedas of 2026-11-07

    48. [48]

      In week 44 of 2026, ECDC reported that respiratory illness in the EU/EEA remained at baseline or low levels, with influenza activity low but increasing in several countries and SARS-CoV-2 the main contributor. confirmedas of 2026-11-06

    Revision history (1)
    1. Page created.

    Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Feb 7, 2027.

    Cite this page

    "COVID-19 explained: symptoms, tests, vaccines and 2026-27 advice." ContentLora, updated Nov 7, 2026. https://contentlora.com/explain/covid-19-explained

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.